Adherence to care processes and surgical outcomes varies by population subgroups for the same procedure. Enhanced recovery after surgery pathways are intended to standardize care, but their effect on process adherence and outcomes for population subgroups is unknown.
nhanced recovery after surgery (ERAS) pathways have proliferated over the past 20 years following the demonstration of markedly improved outcomes.
1,2 These pathway-driven programs focus on marshaling evidence-based principles into everyday clinical practice. Results have varied, but most ERAS pathways have demonstrated a number of clinical successes including reduced length of stay, decreased complications, and increased patient satisfaction. 1, 2 Over a similar chronological period, there have been increasingly documented socioeconomic and racial disparities following surgery. [3] [4] [5] [6] [7] [8] [9] [10] [11] These differences in outcomes are thought to result from the broad population health inequalities observed in the United States where income level alone is associated with more than 10 years of decreased life expectancy. 12 Clinical pathways have been found to ameliorate disparities in care. 13, 14 However, generic care pathways may not be appropriate for all patients.
The need for population-specific ERAS modifications are already well recognized, 15 ,16 yet the effect of ERAS pathways as an additional quality adjunct for surgical disparities is not well understood. Given the beneficial effects that ERAS pathways have already demonstrated, addressing variation in the effect based on racial and socioeconomic groups may be necessary. With the proliferation of ERAS pathways in the United States, understanding population-specific differences is an important gap in our current knowledge base.
The purpose of this study was to examine the effect of ERAS pathways on racial and socioeconomic disparities in a colorectal surgery population with attention to differences in processes of care. We hypothesized that ERAS would improve surgical disparities for these historically vulnerable subgroups.
MATERIALS AND METHODS
A retrospective analysis of prospectively collected data was performed before and after colorectal ERAS pathway implementation at a single academic medical center. All adult patients undergoing elective, major colorectal surgery (Current Procedural Terminology codes 44140-44160, 45110-45123, 44202-44213, 45395, 45397) between January 1, 2013, and June 30, 2016 , were included with the exception of all cases in January 2014 because of a 1-month lead-in to a comprehensive ERAS pathway beginning February 1, 2014. This institution's organizational approach and selection process for ERAS pathway components has been previously described. 17 All surgeons included in the study were colorectal board certified.
Patient data were aggregated from 2 prospective databases. Demographics (eg, age, sex), comorbidities (eg, liver disease, renal failure), and outcomes (eg, complications, length of stay, mortality) were obtained from the institution's National Surgical Quality Improvement Program (NSQIP) internal database that captured all major colorectal procedures performed during the period, with the exception of six 8-day vacation cycles provided by NSQIP reporting policies. 18 Cases with missing outcome data were omitted from the respective univariable analysis.
Data regarding participation in ERAS and adherence to prospectively determined process measures were obtained from a quality improvement database maintained by the institution's Department of Surgery. Adherence was assessed by using electronic medical record automated abstraction scripts of quantitative data captured during the patient's preoperative interview and inpatient stay. Each process measure was a dichotomous variable with errors of omission and commission treated similarly. Protocol adherence at the patient level was defined as achieving completion of the 75th percentile of binary process measures. Cases not found independently in each of the 2 databases were dropped from analysis. Each patient was also assigned an Agency for Healthcare Research and Quality Socioeconomic Status (SES) Index score based on home address zip code, the most segmented standardized SES data available. 19 "Low" SES was defined as an SES index score less than 53, corresponding to the lower half of a US standard population, or those on Medicaid. "High" SES included all who were not low SES.
Outcomes for white and nonwhite patients as well as low versus high SES index scores were analyzed by using χ 2 and Wilcox-Mann-Whitney tests to compare pre-and postimplementation surgical outcomes within groups. Out-group differences were compared by using a difference-in-difference approach. 20 Enhanced recovery after surgery pathway adherence was further compared with patients' surgical outcomes with respect to race and SES. To evaluate our findings, given the imbalance in sample size, we utilized propensity score near-neighbor matching after utilizing logistic regression analysis to create the propensity score and test the balance of covariates in our model. 21 This study was reviewed and approved by the Johns Hopkins School of Medicine Institutional Review Board with an informed consent waiver granted.
RESULTS
A total of 639 colon and rectal resections were identified (199 pre-ERAS era, 440 ERAS era). Of the ERAS era cohort, 338 (76.8%) were white and 102 (23.2%) were nonwhite; 399 (90.7%) were high SES and 41 (9.3%) were low SES. White patients were more likely to carry commercial health insurance (p < 0.001) in the pre-ERAS and ERAS eras. In the pre-ERAS era, white patients were more likely to undergo an open procedure (p = 0.04). In the ERAS era, white patients were less likely to be diabetic (p = 0.03); high SES index patients were less likely to smoke cigarettes and more likely to be employed than the low SES index cohort (p < 0.001 for both) ( Tables 1 and 2 ). Surgical outcomes before and following implementation of the ERAS pathway by race and SES index are reported in Tables 3 and 4 . Before ERAS implementation, median lengths of stay, complication rate, and total number of complications were not statistically different between white and nonwhite patients. Following ERAS implementation, median lengths of stay improved in both whites (-1.5 days, p < 0.001) and nonwhites (-1.0 days, p ≤ 0.001) as well as high SES (-1.0 days, p < 0.001) and low SES (-2.0 days, p = 0.003). A difference-in-difference analysis of these length-of-stay changes demonstrated no statistical difference in the temporal change of the outcomes differences by race or SES (p = 0.89 and p = 0.28). Initially, complication rates in both racial (26.4% versus 28.8%, p = 0.73) and SES (27.3% versus 25.0%, p = 1.00) groups were no different and remained unchanged after ERAS implementation (p = 1.00). Also, the average number of complications per surgery was not statistically different pre-and post-ERAS implementation.
Following ERAS implementation, overall short-term surgical outcomes demonstrated no statistically significant associations with process measures (see Data Supplement at http://links.lww.com/DCR/A392). Univariable analysis of process measure adherence demonstrated no statistically significant association with lengths of stay (p = 0.11) or readmission rates (p = 0.19). The propensity score matching alternative approach described in Materials and Methods yielded the same results.
For vulnerable patient groups, process measure adherence following ERAS implementation is described in Table 5 . Adherence to the protocol was defined as completion of at least 10 process measures (75th percentile). Overall adherence was 31.7% in white patients and 26.5% in nonwhite patients (p = 0.32). Stratifying by SES, high SES index patients were more likely to be adherent than low SES index patients (31.8% versus 17.1%, p = 0.05). It is noteworthy that white patients were more likely to have transverse abdominis plane blocks or epidurals initiated and subsequently maintained than their nonwhite counterparts (initiation: 57.1% versus 44.1%. p = 0.02; maintenance: 47.3% versus 34.3%, p = 0.02). A similar trend was seen in high SES patients (55.4% versus 41.5%, p = 0.09). Those with higher SES trended toward increased rates of being placed on an ERAS pathway during scheduling (p = 0.14), and they adhered to at-home preoperative carbohydrate drink loading almost twice as often as their low SES counterparts (47.6 versus 26.8, p = 0.01). Similarly, high SES patients were more likely to be mobilized and ambulating at goal on their second postoperative day than low SES patients (53.6 versus 39.0, p = 0.08).
Because of the asymmetric variation noted in process measures (eg, transverse abdominis plane blocks), further analysis was performed with process measures stratified by phase of care (eg, perioperative, postoperative) ( Table 5 ). All phases of care demonstrated meaningful, although not all significant, differences between groups. Most notably, adherence to preoperative process measures was 36.6% in white patients versus 24.2% in nonwhite patients (p < 0.01). Stratification by SES also demonstrated a similar trend (34.3% in high SES versus 24.5% in low SES, p = 0.15).
DISCUSSION
This study was designed to assess any effect of ERAS pathway implementation on short-term surgical disparities by using one of the largest patient series of ERAS patients from a diverse population (~30% historically nonwhite). With the use of a database that began as part of a processbased quality improvement program, outcomes were examined within the context of both ERAS implementation and the adherence of each patient to individual ERAS process measures. Our findings suggest that short-term disparities appear to be mitigated by quality monitoring. In addition, there were significant differences in process adherence suggestive of shared decision-making dissonance.
These findings are important for the field's current emphasis on eliminating surgical disparities. Practice innovation within colorectal surgery has specifically been found to discriminate by underlying patient demographics. 22 Surgical disparities have been shown to diminish when surgery is conducted in quality-oriented environments. 23, 24 Some of these disparities in short-term surgical outcomes may be reduced for surgery performed at quality-driven and highvolume centers. 23, 24 Conventional wisdom holds that disparities are due in part to care variation, [25] [26] [27] and bundled pathways may reduce the latter and thereby eliminate disparities. However, one could argue the opposite, that standardized pathways have the potential to worsen disparities because of the lack of individualized adjustment to a patient's unique needs. 28 Of course, a final possibility is that quality-driven centers have already mitigated short-term surgical disparities, and the association of quality-driven institutions as those most likely to implement bundled pathways, as well, may lead to their having no effect on the symmetry of outcomes in different population groups. Given that the existing literature already suggests that experienced centers have reduced many surgical disparities, 23, 24 the implementation of further quality efforts such as an ERAS pathway may have no effect. This study was designed with these different possible scenarios in mind and with the urgency that any unforeseen surgical pathway-inducing disparities be addressed expeditiously. The population reported here represents a diverse and large number of patients undergoing colorectal surgery treated under an ERAS pathway. Of our study population, 30.2% was nonwhite, whereas most of the large European studies on ERAS and outcomes have not reported race, presumably because of the racial homogeneity of the general population. [29] [30] [31] As has been previously reported by a number of centers with similar pathways, 1,2 patients undergoing elective colorectal surgery on an ERAS pathway had improved lengths of stay compared with historical controls without any worsening of readmission rates. As has been shown previously with high-volume centers that take a quality-driven approach to patient care, 23 patients undergoing colorectal surgery at our institution had similar short-term surgical outcomes regardless of race and SES for years before ERAS implementation. It is reassuring that enrollment in an ERAS pathway did not produce short-term surgical disparities in this population. This study also links ERAS process measures to postoperative outcomes in a manner previously done by European institutions before the widespread deployment in the United States. 30 Our reported adherence here was significantly worse than the 50% to 70% reported in seminal studies. [29] [30] [31] We attribute this difference to our use of a real-world quality improvement database rather than a heavily regulated prospective research protocol. The automated abstraction scripts that were used to obtain process data likely underestimated adherence because of missing data, but this loss of data is assumed to occur in a nondifferential manner and may pose little material effect on results. Outside a formal research protocol, we would expect a considerable drop in process adherence. [29] [30] [31] The adherence findings demonstrate an association between increasing process measure adherence and high SES status. Process measure adherence stratified by groups and phase of care favored white and high SES index patients. Adherence to ERAS process measures was not correlated with length of stay or complication rates in this study, but this inconsistency with previously published literature may be because of limited power. Alternatively, the lack of association may be indicative of previous findings that simply measuring quality improvement efforts also reduces these disparities. 23 Given the lack of preexisting racial disparities in our institution's surgical population, an unanswered question for further study is how an ERAS implementation may perform in a more disparate setting. Combined with others' findings, 23 our data support that ERAS pathways may be a useful component of a quality improvement program to reduce differences in surgical care, as well as serve as an early warning monitoring system through the liberal use of detailed process measures. The granularity of these process measures also supports continuous improvement approaches where relative underperformers are targeted even if overall performance appears adequate. 32 Of concern, specific important components of the ERAS pathway were underutilized in historically underserved populations. The rate of epidural use was markedly less in nonwhite patients (44.1% versus 57.1%, p = 0.02) and near-significant in low SES patients (55.4% versus 41.5%, p = 0.09). Two possible interpretations that require further investigation include: 1) nonwhite patients are declining epidural blocks at higher rates because of inadequate counseling regarding the benefits; or 2) providers may be carrying implicit biases that lead to them not offering epidural blocks because of presumed historical preferences of a racial group. 33, 34 It is important that we consider the potential role of implicit bias in our study. 35 Implicit bias from health care professionals represents unrecognized bias against members of a social group affecting the quality of care provided. 36 This has been increasingly recognized to contribute to health care disparities. Implicit bias operates in an unintentional or unconscious manner. It can be activated quickly through social interactions (eg, skin color, accent, or wardrobe) and unnoticeably exert its influence on perception, memory, and behavior. 37 Because implicit bias can operate without a person's intent or awareness, it is reasonable to consider this as an etiology of the disparate use of components of the ERAS pathway observed in this study. The rate of preoperative assignment to the ERAS pathway was only 58.5% in low SES patients, whereas high SES patients were correctly assigned 69.7% of the time (p = 0.14). At our institution, patients were assigned to the ERAS pathway if they met criteria and then were designated to the ERAS pathway as part of surgical case scheduling by the operating surgeon. That low SES patients were less likely to be assigned to the pathway suggests that some stimulus was leading scheduling surgeons to not do so. Enhanced recovery after surgery home medications and infection prevention bundle supplies were provided free-of-charge to all patients as part of their clinic appointment; therefore, it is unlikely that surgeons were omitting low SES patients from the pathway for lack of financial support or resources.
Although our evidence does not prove implicit biases as the cause of these process measure differences, it does heighten concern for its existence. Specifically, concern may be raised with the approach and effectiveness of patient counseling as well as how our providers engage with patients toward a shared goal of comprehensive and equitable care. This finding has resulted in a renewed attention to identify and address implicit biases in care processes at our institution. For example, an ongoing quality improvement process is currently systematically analyzing why rates of regional anesthesia use were markedly lower among nonwhite patients. Future work could focus on reducing disparities by determining the degree of implicit bias in our institution and attempt to understand its relationship with clinical outcomes.
An important corollary of these findings is that an ERAS pathway is likely protective of short-term surgical disparities. We believe that ERAS pathways may intrinsically improve quality through their use of process measures. Some evidence already exists that performance improvement efforts (eg, NSQIP registry use) correlate with reductions in disparities. 38 In this study, we observed ERAS pathway process measures as a quality improvement tool as well as a means of conveying granular quality data to change agents. 39 Given that prior studies have shown that surgeons underutilize quality improvement as a means of addressing surgical disparities, we believe that ERAS pathway process measures may be an important and accessible quality assessment tool and act as a sentinel indicator for surgical disparities. 40 A limitation of this study is that data were analyzed from a single institution with a modified ERAS pathway. It is possible that the lack of short-term disparities in our surgical population and the supportive effect of our institution's ERAS pathway on disparities are unique features of this institution's care environment. Furthermore, each ERAS pathway is unique, and the specific process measures of concern are not generalizable to other institutions. The ERAS experience in the United States is currently lacking robust, multi-institutional studies, but such organizing efforts are just starting to be underway. Even without direct generalizability, the quality-monitoring methods described here offer a framework for further examining subgroup effects of ERAS implementation in other settings. A second limitation is that data were drawn from 2 distinct quality data sets that were not intentionally designed to be merged for chronological analysis. In addition, prior quality improvement and faculty additions limited pre-ERAS historical data collection to only 1 year to limit the effect of temporal trends. Such a limitation affected our ability to capture and merge every case performed at the institution, thereby limiting our sample size and limiting cases to 1 year before ERAS implementation. Although these findings are currently the best available evidence of the ERAS experience in historically vulnerable populations, efforts are underway to further explore the negative results of this study as the postimplementation group continues to accrue. A related limitation is the accuracy of subgroup assignment, specifically national SES indexing. Being able to assign SES accurately is central to further investigation of differences in care, but small-area SES variation is typically not statistically discriminatory using these national metrics. 41 Methods for small-area SES classification such as geocoding have been proposed but their effective use is limited to a few highly studied geographic areas. 42 However, for both race and SES, absolute differences do not appear to be clinically meaningful effects, but a larger sample size may confirm these early findings. A final limitation of many health care quality studies is the debated causal relationship between process measure and outcomes. 43 However, data continue to mount that process measure adherence is associated with improved outcomes, presuming high-quality and appropriate measurement design.
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CONCLUSION
This study's findings are consistent with prior published literature with regard to the lack of short-term surgical outcome disparities at high-quality centers and improvements reported with other ERAS pathway implementations. Enhanced recovery after surgery pathway implementation appears to have no overall benefit or harm on surgical disparities. However, differences in process adherence by racial and socioeconomic group may represent important themes for enhanced quality monitoring. Although these differences are unlikely to be identical at other institutions, the experience described here provides a framework for further work.
